News Releases

Date	Title	Document
Date Dec 16, 2022	Title Oncocyte Announces Initiatives to Focus Corporate Strategy	Document PDF
Date Nov 30, 2022	Title Oncocyte Announces the Appointment of Louis E. Silverman as a Member of Its Board of Directors	Document PDF
Date Nov 30, 2022	Title Oncocyte Announces Executive Leadership Changes	Document PDF
Date Nov 10, 2022	Title Oncocyte Reports Third Quarter 2022 Financial Results	Document PDF
Date Oct 27, 2022	Title Oncocyte to Announce Third Quarter 2022 Financial Results	Document PDF
Date Oct 06, 2022	Title DetermaIO™ Clinical Test to be used in SWOG Cancer Research Network Biomarker Study for Breast Cancer	Document PDF
Date Sep 07, 2022	Title Oncocyte Announces Unanimous Recommendation from the Advisory Panel for Clinical Diagnostic Laboratory Tests on DetermaRx to CMS	Document PDF
Date Aug 31, 2022	Title Oncocyte to Participate at the Lake Street 6th Annual Best Ideas Growth Conference	Document PDF
Date Aug 30, 2022	Title Oncocyte Announces Five-Year VA Contract for DetermaRx	Document PDF
Date Aug 24, 2022	Title Oncocyte Announces Publication of the Validation of DetermaIO in Predicting Immune Therapy Response in Metastatic Bladder Cancer	Document PDF